Single-cell exploration of gene expression and genotypes

Desmoid tumors comprise neoplastic and non-neoplastic cells, but how their cellular composition and interactions influence clinical behavior remains unclear. We are applying integrated single-nucleus and single-cell RNA sequencing with targeted genotyping of CTNNB1 and APC mutations to resolve tumor identity at single-cell resolution. Using biobanked desmoid tumor specimens, we are characterizing transcriptional profiles of genetically defined tumor and non-tumor cells. By linking these molecular profiles to clinical trajectories, we aim to identify gene expression programs associated with spontaneous regression and tumor-specific biology. Understanding these programs may reveal mechanisms that can be leveraged to induce regression in aggressive cases, and help identify patients who could be spared unnecessary or intensive therapy.

biosensor-image

Principal Investigators

Mushriq Al-Jazrawe, PhD (MIT)

Joelle Straehla, MD PhD (Seattle Children's)

Candace Haddox, MD (DFCI)

David Shulman, MD (DFCI)

Aaron Thorner, PhD (DFCI)

Koch InstituteDFCISeattle Children's Research Institute